These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6147392

  • 1. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically.
    Perry TL, Yong VW, Ito M, Foulks JG, Wall RA, Godin DV, Clavier RM.
    J Neurochem; 1984 Oct; 43(4):990-3. PubMed ID: 6147392
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 3. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
    Blunt SB, Jenner P, Marsden CD.
    Neuroscience; 1991 Dec; 43(1):95-110. PubMed ID: 1681462
    [Abstract] [Full Text] [Related]

  • 4. Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys.
    Lyras L, Zeng BY, McKenzie G, Pearce RK, Halliwell B, Jenner P.
    J Neural Transm (Vienna); 2002 Dec; 109(1):53-67. PubMed ID: 11793162
    [Abstract] [Full Text] [Related]

  • 5. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD, De Ceballos ML, Rose S, Jenner P, Marsden CD.
    Eur J Pharmacol; 1992 Aug 25; 219(2):183-92. PubMed ID: 1385171
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and functional differences between dopamine formed from endogenous tyrosine and exogenous L-dopa in nigrostriatal dopaminergic neurons.
    Melamed E.
    Neurochem Int; 1992 Mar 25; 20 Suppl():115S-117S. PubMed ID: 1365408
    [No Abstract] [Full Text] [Related]

  • 7. The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons.
    Keller RW, Kuhr WG, Wightman RM, Zigmond MJ.
    Brain Res; 1988 Apr 26; 447(1):191-4. PubMed ID: 3382951
    [Abstract] [Full Text] [Related]

  • 8. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.
    Andersen JK, Mo JQ, Hom DG, Lee FY, Harnish P, Hamill RW, McNeill TH.
    J Neurochem; 1996 Nov 26; 67(5):2164-71. PubMed ID: 8863527
    [Abstract] [Full Text] [Related]

  • 9. Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.
    Mena MA, Davila V, Sulzer D.
    J Neurochem; 1997 Oct 26; 69(4):1398-408. PubMed ID: 9326268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R.
    Eur J Neurosci; 2008 Feb 26; 27(3):580-92. PubMed ID: 18279311
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.
    Lazzara CA, Riley RR, Rane A, Andersen JK, Kim YH.
    Brain Res; 2015 Oct 05; 1622():127-36. PubMed ID: 26119916
    [Abstract] [Full Text] [Related]

  • 16. L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells.
    Rodríguez-Martín E, Canals S, Casarejos MJ, de Bernardo S, Handler A, Mena MA.
    J Neurochem; 2001 Aug 05; 78(3):535-45. PubMed ID: 11483656
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation.
    Spencer SE, Wooten GF.
    Neurology; 1984 Aug 05; 34(8):1105-8. PubMed ID: 6540390
    [Abstract] [Full Text] [Related]

  • 19. Responses of rat substantia nigra compacta neurones to L-DOPA.
    Mercuri NB, Calabresi P, Bernardi G.
    Br J Pharmacol; 1990 Jun 05; 100(2):257-60. PubMed ID: 2165836
    [Abstract] [Full Text] [Related]

  • 20. Modulation of PC12 cell viability by forskolin-induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons.
    Park KH, Park HJ, Shin KS, Choi HS, Kai M, Lee MK.
    Toxicol Sci; 2012 Jul 05; 128(1):247-57. PubMed ID: 22539619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.